AllianceBernstein’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-69,300
Closed -$1.05M 3345
2022
Q3
$1.05M Buy
69,300
+4,600
+7% +$69.6K ﹤0.01% 2256
2022
Q2
$485K Hold
64,700
﹤0.01% 2697
2022
Q1
$589K Buy
64,700
+200
+0.3% +$1.82K ﹤0.01% 2599
2021
Q4
$453K Hold
64,500
﹤0.01% 2777
2021
Q3
$735K Hold
64,500
﹤0.01% 2605
2021
Q2
$1.03M Buy
64,500
+5,400
+9% +$86.5K ﹤0.01% 2506
2021
Q1
$1.06M Sell
59,100
-7,100
-11% -$127K ﹤0.01% 2377
2020
Q4
$894K Sell
66,200
-5,000
-7% -$67.5K ﹤0.01% 2333
2020
Q3
$838K Sell
71,200
-80,200
-53% -$944K ﹤0.01% 2258
2020
Q2
$2.24M Sell
151,400
-588,844
-80% -$8.69M ﹤0.01% 1776
2020
Q1
$9.99M Buy
740,244
+78,385
+12% +$1.06M 0.01% 907
2019
Q4
$16M Buy
661,859
+117,437
+22% +$2.84M 0.01% 887
2019
Q3
$10.5M Sell
544,422
-41,766
-7% -$803K 0.01% 1028
2019
Q2
$17.3M Sell
586,188
-8,194
-1% -$242K 0.01% 839
2019
Q1
$28.2M Buy
594,382
+17,999
+3% +$855K 0.02% 703
2018
Q4
$20.8M Buy
576,383
+106,047
+23% +$3.83M 0.02% 745
2018
Q3
$28.9M Buy
470,336
+53,484
+13% +$3.29M 0.02% 679
2018
Q2
$28.2M Sell
416,852
-19,907
-5% -$1.34M 0.02% 684
2018
Q1
$23.7M Buy
436,759
+65,683
+18% +$3.56M 0.02% 715
2017
Q4
$22.2M Sell
371,076
-43,654
-11% -$2.61M 0.02% 743
2017
Q3
$20.2M Buy
414,730
+37,346
+10% +$1.82M 0.02% 765
2017
Q2
$19.8M Sell
377,384
-44,258
-10% -$2.33M 0.02% 754
2017
Q1
$19.1M Sell
421,642
-2,041
-0.5% -$92.6K 0.02% 765
2016
Q4
$16M Buy
423,683
+561
+0.1% +$21.2K 0.01% 798
2016
Q3
$16M Sell
423,122
-199,717
-32% -$7.54M 0.01% 781
2016
Q2
$11M Buy
622,839
+71,201
+13% +$1.25M 0.01% 856
2016
Q1
$6.71M Buy
551,638
+25,264
+5% +$307K 0.01% 943
2015
Q4
$12.8M Buy
526,374
+497,474
+1,721% +$12.1M 0.01% 810
2015
Q3
$513K Buy
28,900
+5,600
+24% +$99.4K ﹤0.01% 2464
2015
Q2
$411K Buy
23,300
+16,600
+248% +$293K ﹤0.01% 2645
2015
Q1
$210K Buy
6,700
+5,000
+294% +$157K ﹤0.01% 2801
2014
Q4
$50K Sell
1,700
-1,700
-50% -$50K ﹤0.01% 3099
2014
Q3
$70K Hold
3,400
﹤0.01% 3020
2014
Q2
$84K Buy
+3,400
New +$84K ﹤0.01% 3029